|
Drug Description
DESCRIPTION
Mircette ® (desogestrel/ ethinyl estradiol and ethinyl estradiol) Tablets provide an oral con-traceptive regimen of 21 white tablets each containing 0.15 mg desogestrel (13-ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol), 0.02 mg ethinyl estradiol (19-nor-17 alpha-pregna-1,3,5 (10)-trien-20-yne-3,17-diol), and inactive ingredients which include vitamin E, corn starch, povidone, stearic acid, colloidal silicon dioxide, lactose, hydroxypropyl methylcellulose, polyethylene glycol, titanium dioxide, and talc, followed by 2 green tablets with the following inactive ingredients: lactose, corn starch, magnesium stearate, FD& C Blue No. 2 aluminum lake, yellow ferric oxide, hydroxypropyl methylcellu-lose, polyethylene glycol, titanium dioxide, and talc. Mircette ® also contains 5 yellow tablets containing 0.01 mg ethinyl estradiol (19-nor-17 alpha-pregna-1,3,5 (10)-trien-20-yne-3,17-diol) and inactive ingredients which include vitamin E, corn starch, povidone, stearic acid, colloidal silicon dioxide, lactose, hydroxypropyl methylcellulose, polyethylene glycol, titanium dioxide, talc, and yellow ferric oxide. The molecular weights for desogestrel and ethinyl estradiol are 310.48 and 296.41 respectively. Page: << Prev | 1
|
